Cargando…
Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy
Spinocerebellar ataxia type 2 (SCA2) is an incurable and genetic neurodegenerative disorder. The disease is characterized by progressive degeneration of several brain regions, resulting in severe motor and non-motor clinical manifestations. The mutation causing SCA2 disease is an abnormal expansion...
Autores principales: | Marcelo, Adriana, Afonso, Inês T., Afonso-Reis, Ricardo, Brito, David V. C., Costa, Rafael G., Rosa, Ana, Alves-Cruzeiro, João, Ferreira, Benedita, Henriques, Carina, Nobre, Rui J., Matos, Carlos A., de Almeida, Luís Pereira, Nóbrega, Clévio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630050/ https://www.ncbi.nlm.nih.gov/pubmed/34845184 http://dx.doi.org/10.1038/s41419-021-04404-1 |
Ejemplares similares
-
Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
por: Afonso-Reis, Ricardo, et al.
Publicado: (2021) -
Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review
por: Alves-Cruzeiro, João M. Da Conceição, et al.
Publicado: (2016) -
Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
por: Afonso, Inês T., et al.
Publicado: (2022) -
Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
por: Paulino, Rodrigo, et al.
Publicado: (2023) -
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits
por: Koppenol, Rebekah, et al.
Publicado: (2022)